No Detail Found!

Effect of metoprolol tartrate tablets and recombinant human B-type natriuretic peptide on the sudden cardiac death and malignant arrhythmias in patients with acute myocardial infarction and heart failure

Author(s)
Chenjie Liu Medical Examination Center, Cangzhou Central Hospital,Cangzhou,China
Li Yao Department VI of Cardiovascular Medicine, Cangzhou Central Hospital,Cangzhou,China
Li Zhang CT Scan Room, Cangzhou Central Hospital,Cangzhou,China
Yu Lin Catheterization Room, Cangzhou Central Hospital,Cangzhou,China
Abstract
To explore the effect of metoprolol tartrate tablets and recombinant human natriuretic peptide B (NPPB) on sudden cardiac death and malignant arrhythmias in patients with acute myocardial infarction and patients with heart failure (AMI-HF). A total of 105 AMI-HF patients treatedfrom January 2020 and June 2021 were enrolled and divided into Group I (n=53) and Group II (n=52). Both groups received conventional treatment, and Group II was additionally treated with metoprolol tartrate tablets and NPPB. The clinical observation indicators of the two groups of patients were compared. Group II had better left ventricular end diastolic diameter (LVEDd), left ventricular end systolic diameter (LVESD) and left ventricular ejection fraction (LVEF) (p50ms (pNN50) increased after treatment, with more increase in the Group II (p<0.05). Group II obtained significantly lower levels of B type natriuretic peptide (BNP),N terminal pro B type natriuretic peptide (NT-ProBNP), interleukin (IL)-6 and hs-CRP in contrast to Group I (p<0.05). Markedly higher total response rates were observed in Group II (p<0.05). The combination of metoprolol tartrate tablets and NPPB is effective in treating AMI-HF.
Publication Details
Page(s) 2473-2478
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: S6, Year: 2021

Request the full text from PASTIC

Keywords
Myocardial Infarction, Heart failure, recombinant human B-type natriuretic peptide, metoprolol tartrate tablets
References
Abou el Ela Ael S,Allam AA,Ibrahim EH .2016 .Pharmacokinetics and anti-hypertensive effect of metoprolol tartrate rectal delivery system. Drug Deliv, 23(1) : 69-78.
Allam A,Fetih G .2016 .Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate. Drug Des. Devel. Ther., 10 : 2421-33.
Bocchi EA,Moura LZ,Issa VS,Cruz F,Carvalho VO,Guimaraes GV .2013 .Effects of the recombinant form of the natural human B-type natriuretic peptide and levosimendan on pulmonary hyperventilation and chemosensivity in heart failure. Cardiovasc Ther, 31(2) : 100-7.
Coiro S,Girerd N,Rossignol P,Ferreira JP,Maggioni A,Pitt B,Tritto I,Ambrosio G,Dickstein K,Zannad F K .2017 .Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: A propensity matched-cohort analysis from the high-risk myocardial infarction database initiative. Eur. J. Heart Fail, 19(2) : 271-279.
Dadarwal SC,Madan S,Agrawal SS .2012 .Formulation and evaluation of delayed-onset extendedrelease tablets of metoprolol tartrate using hydrophilicswellable polymers. Acta. Pharm, 62(1) : 105-114.
den Uil CA,Lagrand WK,van der Ent M,Jewbali LS,Cheng JM,Spronk PE,Simoons ML .2010 .Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock. Eur. Heart J., 31(24) : 3032-3039.
El-Battrawy I,Lang S,Ansari U,Tülümen E,Schramm K,Fastner C,Zhou X,Hoffmann U,Borggrefe M,Akin I .2018 .Prevalence of malignant arrhythmia and sudden cardiac death in takotsubo syndrome and its management. Europace., 20(5) : 843-850.
Pak. J. Pharm. Sci. ,Husebye T,Eritsland J,Müller C,Sandvik L,Arnesen H,Seljeflot I,Mangschau A,Bjørnerheim R,Andersen GØ .2013 .Levosimendan in acute heart failure following primary percutaneous coronary interventiontreated acute ST-elevation myocardial infarction. Results from the LEAF trial: A randomized, placebocontrolled study. Eur. J. Heart Fail, 15(5) : 565-572.
Ben Zadok Itzhaki,Hasdai O,Witberg D,Shapira G,Vaturi Y,Monakier D M .2018 .Calculated risk for sudden cardiac death in patients with apical versus nonobstructive nonapical hypertrophic cardiomyopathy. Am. J. Cardiol., 122(9) : 1551-1556.
Kanumuri RM,Bajji C,Tummuru RR,Tatireddigari VR,Mangamoori LN,Panati K,Narala VR K .2015 .Increased yield of high purity recombinant human brain natriuretic peptide by acid hydrolysis of short fusion partner in Escherichia coli. Protein Expr, 111 : 61-7.
Klein S,Seeger N,Mehta R,Missaghi S,Grybos R,Rajabi-Siahboomi A .2018 .Robustness of barrier membrane coated metoprolol tartrate matrix tablets: Drug release evaluation under physiologically relevant in vitro conditions. Int. J. Pharm., 543(1-2) : 368-375.
Lanfear DE,Li J,Abbas R,She R,Padhukasahasram B,Gupta RC,Langholz D,Tang WH,Williams LK,Sabbah HN,Chow SL .2015 .Genetic factors influencing B-type natriuretic peptide-mediated production of cyclic guanosine monophosphate and blood pressure effects in heart failure patients. J. Cardiovasc. Transl. Res., 8(9) : 545-53.
Le S,Xiao J,Li W,Wang J,Wang Q,Xi W,Xu J,Wang Z J .2017 .Continuous administration of recombinant human B-type natriuretic peptide can improve heart and renal function in patients after cardiopulmonary bypass surgery. J. Thorac. Dis., 9(3) : 692-701.
Lesko LJ,Offman E,Brew CT,Garza D,Benton W,Mayo MR,Romero A,Du Mond C,Weir MR C .2017 .Evaluation of the potential for drug interactions with patiromer in healthy volunteers. J. Cardiovasc. Pharmacol. Ther., 22(5) : 434-446.
Ng GA .2016 .Neuro-cardiac interaction in malignant ventricular arrhythmia and sudden cardiac death. Auton Neurosci, 199 : 66-79.
Noori VJ,Healey CT,Eldrup-Jorgensen J,Blazick E,Hawkins RE,Bloch PHS,Nolan BW .2019 .Comparison of major adverse event rates after elective endovascular aneurysm repair in New England using a novel measure of complication severity. J. Vasc. Surg., 70(1) : 74-79.
Pocrnić M,Ansorge M,Dovhunová M,Habinovec I,Tesařová E,Galic N E .2020 .Chiral separation of beta-blockers by high-performance liquid chromatography and determination of bisoprolol enantiomers in surface waters. Arh. Hig. Rada. Toksikol., 71(1) : 56-62.
Rameau A,de With E,Boerma EC .2017 .Passive leg raise testing effectively reduces fluid administration in septic shock after correction of non-compliance to test results. Ann. Intensive Care, 7(1) : 2.
Rossello X,Ferreira JP,McMurray JJ,Aguilar D,Pfeffer MA,Pitt B,Dickstein K,Girerd N,Rossignol P,Zannad F,High-Risk Myocardial Infarction Database Initiative F .2019 .Editor's choice-impact of insulintreated diabetes on cardiovascular outcomes following high-risk myocardial infarction. Eur. Heart J. Acute Cardiovasc Care, 8(3) : 231-241.
Siddique S,Khanam J,Bigoniya P .2010 .Development of sustained release capsules containing coated matrix granules of metoprolol tartrate. AAPS Pharm. Sci. Tech, 11(3) : 1306-14.
Song L,He S,Ping Q .2017 .Development of a sustained-release microcapsule for delivery of metoprolol succinate. Exp. Ther. Med, 13(5) : 2435-2441.
van Nunen LX,van't Veer M,Zimmermann FM,Wijnbergen I,Brueren GRG,Tonino PAL,Aarnoudse WA,Pijls NHJ .2020 .Intra-aortic balloon pump counterpulsation in extensive myocardial infarction with persistent ischemia: The SEMPER FI pilot study. Catheter Cardiovasc Interv., 95(1) : 128-135.
Vora BN,Parmar RR,Nayak PP,Shah DA PP .2012 .Development and validation of the simultaneous UV spectrophotometric method for estimation of metoprolol succinate and olmesartan medoxomil in the tablet dosage form. Pharm. Methods, 3(1) : 44-7.
Watanabe R,Suzuki J,Wakayama K,Kumagai H,Ikeda Y,Akazawa H,Komuro I,Isobe M .2016 .Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure. Hypertens Res., 39(4) : 237-44.
Zhang S,Raedschelders K,Santos M and Van Eyk JE .2017 .Profiling B-type natriuretic peptide cleavage peptidoforms in human plasma by capillary electrophoresis with electrospray ionization mass spectrometry. J. Proteome. Res., 16(12) : 4515-4522.
0

Citations

0

Downloads

10

Views